Shenzhen, [September 29] C&O today announces the launch of its first next-generation proton pump inhibitor, Rabeprazole Sodium for Injection (Aobo Ping®), in China. Aubergine® is a self-developed product of C&O.
MoreRabeprazole Sodium for Injection (Aobo Ping®) has been approved for drug registration and will be launched soon!
MoreContact telephone numbers for Rabeprazole Sodium for Injection (Aobo Ping) in provinces
MoreRabeprazole Sodium for Injection (Aobo Ping®) agent registration form
More
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mail[email protected]
Official WeChat account 
Mobile page